About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Trials Show Promising Drug Targets In Pulmonary Hypertension

by Dr. Meenakshy Varier on August 23, 2016 at 1:27 PM
Font : A-A+

New Trials Show Promising Drug Targets In Pulmonary Hypertension

A groundbreaking new study led by researchers from the University of Pittsburgh and UPMC has identified a new group of compounds that could have robust effects in treating pulmonary hypertension (PH), an enigmatic but sometimes fatal disease of the blood vessels of the lungs that currently has no cure. The findings, which were published in the Journal of Clinical Investigation, highlight the use of these drugs to alter vessel stiffness and its downstream control of metabolism, a link previously unknown for people suffering from the progressive disease .

"If we aim to cure this disease, the next set of medications and treatments should be those that target the origin at the molecular level," said Stephen Y. Chan, M.D., Ph.D., director of the UPMC Center for Pulmonary Vascular Biology and Medicine at the Vascular Medicine Institute at Pitt, and senior author of the study. "As a community, we are struggling right now to understand those origins of PH, and this study aimed to address that untapped need."

Advertisement


Affecting tens of millions of people worldwide, PH is high blood pressure in the arteries in the lungs, which makes it difficult for blood to flow from the heart to the lungs. Symptoms of the disease, which can lead to heart failure, include shortness of breath, fatigue and chest pain; and, in its early stages, might not be noticeable for months or even years. Often a life-threatening condition, it becomes progressively worse, making early and accurate diagnosis important to allow treatments that extend and improve the quality of life for many patients.

To make these discoveries, Dr. Chan and his colleagues used a comprehensive array of tools derived from cells and tissues of animal and humans with PH. Notably, these findings also were relevant to PH caused by human immunodeficiency virus (HIV) infection, a particularly mysterious form of this disease where the underlying molecular processes have remained unknown for decades.
Advertisement

Dr. Chan's team found that stiffening or hardening of the vessels in the lung is an early event in PH that triggers the activation of two critical signaling molecules called YAP and TAZ. These molecules in turn activate a protein called GLS1, which controls how cells in the vessel produce and use energy.

"The link between vessel hardening and energy production is absolutely central to this disease," said Dr. Chan. "That discovery offers us so many new ways to design drugs tailor-made to stop PH in its tracks."

As proof-of-concept, Dr. Chan's team tested both the YAP inhibitor verteporfin, a Food and Drug Administration-approved medication for macular degeneration, and a GLS1 inhibitor called CB-839, which is in clinical trials for cancer. They found that both of these compounds displayed robust effects in improving PH in a rodent model of disease.

"We are very encouraged by these results," said Dr. Chan. "We are working to re-purpose these drugs for treatment of human PH, which now can include long-neglected disease types such as HIV-related conditions and others. We hope that we can do so without the delay of decades that often happens when developing new compounds from scratch."

Given that vessel stiffness is prevalent in other diseases, including cancer progression, these results also may be important beyond PH, noted Dr. Chan. "There is always more work to be done," he said. "But, we feel this represents a significant milestone in our quest to cure this disease."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Diet Lifestyle and Heart Disease Diet and High Blood Pressure Signature Drug Toxicity Stress and the Gender Divide Silent Killer Diseases Quiz on Hypertension Can Garlic Control High Blood Pressure High Blood Pressure and Herbs Benefits of Blood Pressure Tablets on your Health 

Most Popular on Medindia

Post-Nasal Drip Loram (2 mg) (Lorazepam) Vent Forte (Theophylline) Indian Medical Journals Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) Daily Calorie Requirements Calculate Ideal Weight for Infants Nutam (400mg) (Piracetam) Blood Donation - Recipients
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Trials Show Promising Drug Targets In Pulmonary Hypertension Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests